ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2025
[Construction of the Chinese-Western Synergistic System for the Prevention and Treatment of Diabetic Lower Extremity Arterial Disease].
Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic lower extremity arterial disease (DLEAD) is characterized by a low rate of diagnosis, low awareness, low treatment rate, high disability rate, and high mortality. Due to a lack of comprehensive prevention and treatment strategies or an integrated technological system, DLEAD has become a bottleneck in the prevention and control of diabetes mellitus at present. Traditional Chinese medicine (TCM) treatment of DLEAD offers the advantages of syndrome differentiation, evidence-based treatment, and holistic regulation. However, it lacks a comprehensive understanding of the through-course pathogenesis and unified standardized syndrome criteria. TCM treatment of DLEAD exerts multi-target and multi-pathway network effects, but the advantageous links are still not fully understood. TCM treatments can delay the onset and development of DLEAD, but the efficacy evaluation system remains incomplete. Furthermore, there is a lack of high-quality evidence-based medical evidence and clinical consensus and guidelines. Therefore, based on the idea of zhi wei bing, or treating the disease before it develops, in Chinese medicine, and focusing on the prevention and control of DLEAD, we have constructed a synergistic technical system that integrates traditional Chinese and Western medicine for the prevention and control of DLEAD. This system integrates prevention, diagnosis, treatment, mechanisms, and applications, so as to enhance the clinical effects of DLEAD prevention and control, and to create a new paradigm for collaborative traditional Chinese medicine and western medicine in the field of chronic disease management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.